(lp0
S"Arca Biopharma Inc  Announces The Enrollment Of The Randomized ... Journal Transcript - Mar 8, 2017 Arca Biopharma Inc , announced that 175 patients have been randomized into GENETIC-AF. It's a unique design Phase 2B/3 clinical trial for the evaluation of a new drug - Gencaro (bucindolol hydrochloride, a beta blocker and a mild&nbsp;..."
p1
aS'Stock Momentum in Focus on Shares of ARCA Biopharma Inc  Rives Journal - 16 hours ago Currently, the 14-day ADX for ARCA Biopharma Inc  is 20.18. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend.'
p2
aS'Why Arca Biopharma Is A Buy Seeking Alpha - Jan 14, 2014 Arca Biopharma  is a pre-revenue company that has patents through 2029 covering the drug Gencaro .'
p3
aS'PT Watch on These Stocks: Verso Corporation  ARCA biopharma, Inc ... Rives Journal - 19 hours ago Stock research firms currently have a positive stance on shares of Verso Corporation . Analysts are projecting that the stock will reach $25.00 on a short term  basis.'
p4
aS'Arca Biopharma Inc  Announces 175th Patient Randomized into the ... Journal Transcript - Mar 7, 2017 Arca Biopharma Inc , a biopharmaceutical company that develops genetically-oriented therapies meant for treatment of cardiovascular diseases has announced randomizing the GENETIC-AF.ARCA Biopharma, Inc.  Broker Price Targets For The Coming Week - Fiscal Standard'
p5
aS'ARCA biopharma, Inc.  Files An 8-K Departure of Directors or ... Market Exclusive - Feb 21, 2017 ARCA biopharma, Inc.  Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.'
p6
aS'ARCA biopharma, Inc.   Top Stock from Healthcare Sector The Daily Leicester - 5 hours ago ARCA biopharma, Inc. , a Biotechnology company from Healthcare sector has been doing very well. The company has reported a price of $2.5 today, marking a change of 6.38%.'
p7
aS'Arca Biopharma  Enters Agreement to Offer Up to $7.3M in Common Stock StreetInsider.com - Jan 11, 2017 On January 11, 2017, ARCA biopharma, Inc.  entered into a Capital on DemandTM Sales Agreement  with JonesTrading Institutional Services LLC, as agent , pursuant to which the Company may offer&nbsp;...'
p8
aS'Interview with the COO: ARCA biopharma, Inc.  The Wall Street Transcript - Mar 10, 2017 Thomas A. Keuer is Chief Operating Officer of ARCA biopharma, Inc. Mr. Keuer was appointed to his current position as Chief Operating Officer in December 2014.'
p9
aS'Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire  - Jan 18, 2017 WESTMINSTER, Colo.----ARCA biopharma, Inc. , a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that the&nbsp;...'
p10
a.